Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 65

Using tranexamic acid to reduce inflammation in traumatic brain injury

Official title: The Impact of Early Use of Dexamethasone Traumatic Brain Injury Upon the Inflammatory Response and Outcome

Run by Assiut University · NCT05323149 · Data updated 2026-11-12

This study is testing if giving tranexamic acid to patients with traumatic brain injury can help reduce inflammation and improve their recovery.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorAssiut University
Academic / other
Locations1 site (Asyut, Assuit)
StatusRecruiting
StartedMay 18, 2022
Main results expectedSeptember 10, 2027
Study endsOctober 15, 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT05323149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with isolated mild to moderate traumatic brain injuries and a Glasgow Coma Scale score greater than 8.

Probably not a fit

Patients who are in cardiac arrest, have coagulopathies, renal failure, are pregnant, or refuse to participate may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This double-blind phase 3 trial investigates the effects of tranexamic acid (TXA) on inflammation in patients with traumatic brain injury (TBI). Participants will be randomly assigned to receive either TXA or a saline placebo after initial resuscitation in the emergency room. The study will monitor various inflammatory markers and clinical outcomes, including the Glasgow Coma Scale and hemodynamic stability, over a period of 48 hours. The goal is to determine if TXA can effectively modulate the inflammatory response associated with TBI.

Why it matters

Potential benefit: If successful, this treatment could lead to improved outcomes for patients suffering from traumatic brain injuries by reducing inflammation.

How similar studies have gone: While the use of tranexamic acid has shown promise in other trauma settings, this specific application in TBI is still being explored and is considered novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Isolated traumatic brain injury patients (mild or moderate cases)
* GCS \> 8
* non penetrating TBI in 8 hours onset
* Age ≥ 18 years

Exclusion Criteria:

* Patient in cardiac arrest
* Patients with coagulopathies
* All diabetic patients
* Renal failure patients
* pregnancy
* Patient refusal to participate

Where it's running

  • Assiut university hospital
    Asyut, Assuit, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.